Edwin R Burrell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 Wentworth Ave E, West Saint Paul, MN 55118 Phone: 651-455-2940 Fax: 651-455-3354 |
James R. Benzie, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 234 Wentworth Ave E, West Saint Paul, MN 55118 Phone: 651-788-4444 Fax: 651-455-3354 |
Elizabeth Gilbertson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 Emerson Ave E, West Saint Paul, MN 55118 Phone: 651-241-1800 |
Timothy J Hernandez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 234 Wentworth Ave E, West Saint Paul, MN 55118 Phone: 651-455-2940 Fax: 651-455-3354 |
News Archive
Primco Management Inc., a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.
The Foundation for Education and Musculoskeletal Research (FEMR) and the state of Illinois officially proclaimed the first day of autumn, September 22, 2010, as Fall Prevention Awareness Day. FEMR will be raising awareness for fall prevention and the need for osteoporosis screening and treatment in an effort to reduce the incidence of fragility bone fractures among older residents of Illinois.
Medifast, Inc., a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, announced today that Timothy Robinson, Chief Financial Officer, and Meg Sheetz, President and Chief Operating Officer, will present at the Jefferies 2014 Global Consumer Conference on Thursday, June 19, 2014 in Nantucket, MA.
Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.
› Verified 8 days ago